10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001628280-25-021571`
Period End Date	20250331
Filing Date	20250501
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	alhc-20250331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 150 Income Statement 80 Cash Flow Statement 146 Stockholders Equity 42

Balance Sheet 150 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$446.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$446.18M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$153.90M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$153.90M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$214.06M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $0 at March 31, 2025 and $0 at December 31, 2024)	`AccountsReceivableNetCurrent`	$214.06M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$37.79M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$37.79M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - current	`ShortTermInvestments`	$33.36M	USD	Point-in-time
Investments - current	`ShortTermInvestments`	$33.36M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$37.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$37.08M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$80.88M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$80.88M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$774.49M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$774.49M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$661.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$661.64M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.78M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	191.78M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$67.14M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	197.67M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	197.67M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$68.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$68.50M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	197.67M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	197.67M	shares	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.82M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.82M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.75M	USD	Point-in-time
Right of use asset, net	`LeaseRightOfUseAssets`	$7.75M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.83M	USD	Point-in-time
Goodwill	`Goodwill`	$34.19M	USD	Point-in-time
Goodwill	`Goodwill`	$34.19M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.55M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.09M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.09M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.13M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.13M	USD	Point-in-time
Total assets	`Assets`	$895.62M	USD	Point-in-time
Total assets	`Assets`	$895.62M	USD	Point-in-time
Total assets	`Assets`	$782.06M	USD	Point-in-time
Total assets	`Assets`	$782.06M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$289.79M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$289.79M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$396.73M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$396.73M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$22.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$28.03M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$28.03M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$39.93M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$39.93M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$32.35M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$32.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$351.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$351.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$457.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$457.12M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.43M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.43M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.86M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$321.86M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.65M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.65M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Long-term portion of lease liabilities	`LeaseLiabilityNoncurrent`	$7.83M	USD	Point-in-time
Total liabilities	`Liabilities`	$786.62M	USD	Point-in-time
Total liabilities	`Liabilities`	$786.62M	USD	Point-in-time
Total liabilities	`Liabilities`	$681.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$681.11M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of March 31, 2025 and December 31, 2024	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 197,667,653 and 191,778,639 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$198.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 197,667,653 and 191,778,639 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$198.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 197,667,653 and 191,778,639 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$192.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 197,667,653 and 191,778,639 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$192.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.11B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.11B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.13B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.02B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.02B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$99.85M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$99.85M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$108.13M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$108.13M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.10M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.10M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$864.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$864.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$782.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$782.06M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$895.62M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$895.62M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$918.04M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$918.04M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$621.56M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$621.56M	USD	1 Quarter
Other	`OtherIncome`	$8.89M	USD	1 Quarter
Other	`OtherIncome`	$8.89M	USD	1 Quarter
Other	`OtherIncome`	$7.04M	USD	1 Quarter
Other	`OtherIncome`	$7.04M	USD	1 Quarter
Total revenues	`Revenues`	$926.93M	USD	1 Quarter
Total revenues	`Revenues`	$926.93M	USD	1 Quarter
Total revenues	`Revenues`	$628.60M	USD	1 Quarter
Total revenues	`Revenues`	$628.60M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$820.90M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$820.90M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$573.22M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$573.22M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.51M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$90.51M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$103.83M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$103.83M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.98M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.59M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.59M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$932.33M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$932.33M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$669.71M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$669.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-41.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-41.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.39M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.39M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.95M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$3.95M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.43M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$5.43M	USD	1 Quarter
Other (income) expenses, net	`OtherNonoperatingIncomeExpense`	$10.00K	USD	1 Quarter
Other (income) expenses, net	`OtherNonoperatingIncomeExpense`	$10.00K	USD	1 Quarter
Other (income) expenses, net	`OtherNonoperatingIncomeExpense`	$-42.00K	USD	1 Quarter
Other (income) expenses, net	`OtherNonoperatingIncomeExpense`	$-42.00K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-5.47M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-5.47M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-3.94M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-3.94M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-9.33M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-9.33M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-46.58M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-46.58M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$21.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$21.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-9.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-9.35M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-240.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-240.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-54.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-54.00K	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-9.11M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-9.11M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-46.52M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-46.52M	USD	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	193.61M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	193.61M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	189.01M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	193.61M	shares	1 Quarter
Total weighted-average common shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	193.61M	shares	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.05	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.05	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.25	USD	1 Quarter
Net loss per share - basic (in dollars per share)	`EarningsPerShareBasic`	$-0.25	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.05	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.05	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.25	USD	1 Quarter
Net loss per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.25	USD	1 Quarter

Cash Flow Statement 146 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-9.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-9.35M	USD	1 Quarter
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-143.00K	USD	1 Quarter
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	$-143.00K	USD	1 Quarter
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	-	USD	1 Quarter
Loss on right of use assets	`GainLossOnOperatingLeaseRightOfUseAsset`	-	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$6.03M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$6.03M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$7.63M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$7.63M	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.15M	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.15M	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$370.00K	USD	1 Quarter
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$370.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$440.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$440.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$520.00K	USD	1 Quarter
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$520.00K	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$20.85M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$20.85M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$17.19M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$17.19M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$472.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$472.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$395.00K	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$395.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$45.32M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$45.32M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$60.16M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$60.16M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.89M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.89M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.80M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.80M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$114.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$114.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$23.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$23.00K	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$106.95M	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$106.95M	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$71.06M	USD	1 Quarter
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$71.06M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$48.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$48.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$5.21M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$5.21M	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-59.00K	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-59.00K	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$157.00K	USD	1 Quarter
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$157.00K	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-7.58M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-7.58M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-2.50M	USD	1 Quarter
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-2.50M	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-755.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-755.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-65.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-65.00K	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.62M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.62M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.24M	USD	1 Quarter
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.24M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$17.91M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$17.91M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$21.56M	USD	1 Quarter
Purchase of investments	`PaymentsToAcquireInvestments`	$21.56M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$22.70M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$22.70M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$75.39M	USD	1 Quarter
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments`	$75.39M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.12M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.12M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.25M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.25M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$42.70M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$42.70M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.46M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.46M	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	1 Quarter
Payment of employment taxes related to release of restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$26.00K	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$26.00K	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$207.00K	USD	1 Quarter
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	$207.00K	USD	1 Quarter
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Proceeds from stock option exercises	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$15.00K	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	1 Quarter
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$181.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$181.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-335.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-335.00K	USD	1 Quarter
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$36.13M	USD	1 Quarter
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$36.13M	USD	1 Quarter
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$13.34M	USD	1 Quarter
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$13.34M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$448.28M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$448.28M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$448.28M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$448.28M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$5.17M	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$5.17M	USD	1 Quarter
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$85.00K	USD	1 Quarter
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$85.00K	USD	1 Quarter
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$156.00K	USD	1 Quarter
Acquisition of property in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$156.00K	USD	1 Quarter
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$432.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$446.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$446.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$238.90M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.18M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.18M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.09M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$2.09M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$241.09M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$434.94M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$448.28M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$448.28M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$204.95M	USD	Point-in-time

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	197.67M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	197.67M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-46.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-9.35M	USD	1 Quarter
Net loss	`ProfitLoss`	$-9.35M	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$2.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$2.00K	USD	1 Quarter
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Shares withheld related to net restricted stock settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$350.00K	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$17.19M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$17.19M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$20.85M	USD	1 Quarter
Equity-based compensation	`StockGrantedDuringPeriodValueSharebasedCompensation`	$20.85M	USD	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	24,472.00	shares	1 Quarter
Stock options exercised (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	24,472.00	shares	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$207.00K	USD	1 Quarter
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$207.00K	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	1 Quarter
Ending Balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	191.78M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	197.67M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	197.67M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.95M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$132.02M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$158.07M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.